Envista (NYSE:NVST) Stock Rating Lowered by Wall Street Zen

Envista (NYSE:NVST) was downgraded by research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Saturday, Wall Street Zen reports.

NVST has been the subject of several other reports. JPMorgan Chase & Co. raised Envista from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $29.00 to $32.00 in a research note on Thursday. Mizuho set a $29.00 target price on Envista in a research report on Thursday, August 6th. Weiss Ratings upgraded Envista from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Piper Sandler restated a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. Finally, Robert W. Baird set a $34.00 price target on Envista in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $29.71.

Envista Stock Down 0.6%

Shares of NYSE NVST opened at $27.12 on Friday. The firm’s 50-day moving average price is $27.23 and its 200-day moving average price is $26.27. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $4.36 billion, a price-to-earnings ratio of 46.76, a P/E/G ratio of 1.30 and a beta of 0.86. Envista has a 12-month low of $18.77 and a 12-month high of $30.42.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. During the same quarter last year, the business posted $0.26 earnings per share. The firm’s revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities research analysts anticipate that Envista will post 1.53 EPS for the current fiscal year.

Insider Transactions at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Envista

Large investors have recently bought and sold shares of the business. Parkside Financial Bank & Trust grew its position in Envista by 246.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 3,071 shares of the company’s stock valued at $81,000 after acquiring an additional 2,184 shares during the last quarter. Corient Private Wealth LP increased its stake in Envista by 35.8% in the second quarter. Corient Private Wealth LP now owns 703,864 shares of the company’s stock worth $18,547,000 after purchasing an additional 185,687 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Envista in the second quarter worth $992,000. California State Teachers Retirement System lifted its position in shares of Envista by 2,460.3% during the second quarter. California State Teachers Retirement System now owns 4,972,429 shares of the company’s stock worth $131,024,000 after purchasing an additional 4,778,217 shares during the last quarter. Finally, AlphaGrep UK Ltd bought a new stake in shares of Envista during the second quarter worth $338,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.